• Company Type For Profit
  • Phone Number 33-(0)-240-358-999

TcLand Expression is a fully integrated company displaying high expertise in all stages of biomarker development: R&D, bioinformatics & biostatistics, clinical & regulatory , market access and production.

TcLand Expression is a pioneer and European leader in personalized medicine in immunology (transplantation and auto-immune

disorders) with a rich pipeline of biomarkers in development.

Lists Featuring This Company

Europe, Middle East, and Africa (EMEA) Startups Founded in 2001
101 Number of Organizations â€¢ $787M Total Funding Amount â€¢ 227 Number of Investors
Advertising Early Stage Companies With Fewer Than 50 Employees
443 Number of Organizations â€¢ $2.7B Total Funding Amount â€¢ 1,419 Number of Investors
Europe Early Stage Companies With More Than $10M in Revenue
801 Number of Organizations â€¢ $34.4B Total Funding Amount â€¢ 5,111 Number of Investors
Web Development Companies With Fewer Than 50 Employees (Top 10K)
9,972 Number of Organizations â€¢ $4.2B Total Funding Amount â€¢ 3,000 Number of Investors

Frequently Asked Questions

Where is NGI's headquarters? NGI is located in Nantes, Pays de la Loire, France.Who invested in NGI? NGI has 4 investors including Quest for Growth and Auriga Partners.How much funding has NGI raised to date? NGI has raised .When was the last funding round for NGI? NGI closed its last funding round on Dec 19, 2007 from a Series A round.Who are NGI's competitors? Alternatives and possible competitors to NGI may include HeroStudio Zenz, and new-webshop.